Low high-density lipoprotein 3 reduces the odds of men surviving to age 85 during 53-year follow-up

Journal of the American Geriatrics Society

Volumn 60, Issue 3, 2012, Pages 430-436

  Williams, Paul T ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

epidemiology; lipoprotein; longevity

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 3; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CANCER RISK; CIGARETTE SMOKING; CONCENTRATION RESPONSE; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; LIPOPROTEIN BLOOD LEVEL; LONGEVITY; MALE; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE;

AGED, 80 AND OVER; ANTHROPOMETRY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPOPROTEINS, HDL3; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84858340935     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03851.x     Document Type: Article

References (40)

1. Arias E,. United States life tables, 2006. Natl Vital Stat Rep 2010; 58: 1-40.
2. Campbell AJ, Busby WJ, Roberson MC,. Over 80 years and no evidence of coronary heart disease: Characteristics of a survivor group. J Am Geriatr Soc 1993; 41: 1333-1338.
3. Nikkilä M, Pitkäjärvi T, Koivula T, et al. Elevated high density-lipoprotein cholesterol and normal triglycerides as markers of longevity. Klin Wochenschr 1991; 69: 780-785.
4. Nikkilä M, Heikkinen J,. High-density lipoprotein cholesterol and longevity. Age Ageing 1990; 19: 119-124.
5. Barzilai N, Atzmon G, Schecter C, et al. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA 2003; 290: 2030-2040.
6. Rahilly-Tierney CR, Spiro A III, Vokonas P, et al. Relation between high-density lipoprotein cholesterol and survival to age 85 years in men (from the VA Normative Aging Study). Am J Cardiol 2011; 107: 1173-1177.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
8. Wilson PW, Garrison RJ, Castelli WP, et al. Prevalence of coronary heart disease in the Framingham Offspring Study: Role of lipoprotein cholesterols. Am J Cardiol 1980; 46: 649-654.
9. Assmann G, Schulte H, von Eckardstein A, et al. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk: The PROCAM experience an pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996; 124 (suppl 6): S11-S20.
10. Nichols AV, Krauss RM, Musliner TA,. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol 1986; 128: 417-431.
11. Barter PJ, Nicholls S, Rye KA, et al. Antiinflammatory properties of HDL. Circ Res 2004; 95: 764-772.
12. Mineo C, Deguchi H, Griffin JH, et al. Endothelial and antithrombotic actions of HDL. Circ Res 2006; 98: 1352-1364.
13. Tall AR,. An overview of reverse cholesterol transport. Eur Heart J 1998; 19 (suppl A): A31-A35.
14. McGrowder D, Riley C, Morrison EY, et al. The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer. Cholesterol 2011; 2011: 496925.
15. Gofman JW, Young W, Tandy R,. Ischemic heart disease, atherosclerosis, and longevity. Circulation 1966; 34: 679-697.
16. Williams PT, Feldman DE,. Prospective study of coronary heart disease vs HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort. Atherosclerosis 2011; 214: 196-202.
17. Williams PT,. Fifty-three year follow-up of coronary heart disease vs HDL2 and other lipoproteins in Gofmans Livermore cohort. J Lipid Res 2011; 53. [Epub ahead of print].
18. Evaluation of serum lipoprotein and cholesterol measurements as predictors of clinical complications of atherosclerosis: Report of a cooperative study of lipoproteins and atherosclerosis. Circulation 1956; 14: 691-742.
19. Colman DM, McPhee AF,. An improved method for determination of total serum cholesterol. Am J Clin Pathol 1956; 26: 181-186.
20. National Death Index User's Manual. Hyattsville, MD: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Center for Health Statistics, 1990.
21. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989; 79: 8-15.
22. Schaefer EJ, Moussa PB, Wilson PW,. Plasma lipoproteins in healthy octogenarians: Lack of reduced high density lipoprotein cholesterol levels: Results from the Framingham Heart Study. Metabolism 1989; 38: 293-296.
23. Williams PT, Krauss RM, Vranizan KM, et al. Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women. Arterioscler Thromb 1992; 12: 332-340.
24. Williams PT, Vranizan KM, Austin MA, et al. Associations of age, adiposity, alcohol intake, menstrual status, and estrogen therapy with high-density lipoprotein subclasses. Arterioscler Thromb 1993; 13: 1654-1661.
25. Williams PT, Haskell WL, Vranizan KM, et al. The associations of high-density lipoprotein subclasses with insulin and glucose levels, physical activity, resting heart rate, and regional adiposity in men with coronary artery disease: The Stanford Coronary Risk Intervention Project baseline survey. Metabolism 1995; 44: 106-614.
26. Williams PT, Krauss RM, Vranizan KM, et al. Effects of weight-loss by exercise and by diet on apolipoproteins A-I and A-II and the particle-size distribution of high-density lipoproteins in men. Metabolism 1992; 41: 441-449.
27. Cheung MC, Albers JJ,. Distribution of cholesterol and apolipoprotein A-I and A-II in human high density lipoprotein subfractions separated by CsCl equilibrium gradient centrifugation: Evidence for HDL subpopulations with differing A-I/A-II molar ratios. J Lipid Res 1979; 20: 200-207.
28. Cheung MC, Albers JJ,. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. J Biol Chem 1984; 259: 12201-12209.
29. Ettinger WH Jr, Verdery RB, Wahl PW, et al. High density lipoprotein cholesterol subfractions in older people. J Gerontol 1994; 49: M116-M122.
30. Psaty BM, Furberg CD, Kuller LH, et al. Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: The Cardiovascular Health Study. Arch Intern Med 1999; 159: 1339-1347.
31. Yates LB, Djoussé L, Kurth T, et al. Exceptional longevity in men: Modifiable factors associated with survival and function to age 90 years. Arch Intern Med 2008; 168: 284-290.
32. Baggio G, Donazzan S, Monti D, et al. Lipoprotein (a) and lipoprotein profile in healthy centenarians: A reappraisal of vascular risk factors. FASEB J 1998; 12: 433-437.
33. Barter P,. HDL: A recipe for longevity. Atherosclerosis 2004; 5: 25-31.
34. Walter M,. Interrelationships among HDL metabolism, aging, and atherosclerosis. Arterioscler Thromb Vasc Biol 2009; 29: 1244-1250.
35. Ferrara A, Barrett-Connor E, Shan J,. Total, LDL, and HDL cholesterol decrease with age in older men and women The Rancho Bernardo Study 1984-1994. Circulation 1997; 96: 37-43.
36. Johansson J, Carlson LA,. The effects of nicotinic acid treatment on high density lipoprotein particle size subclass levels in hyperlipidaemic subjects. Atherosclerosis 1990; 83: 207-216.
37. Hiukka A, Leinonen E, Jauhiainen M, et al. Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus. Diabetologia 2007; 50: 2067-2075.
38. Williams PT, Krauss RM, Wood PD, et al. Associations of diet and alcohol intake with high-density lipoprotein subclasses. Metabolism 1985; 34: 524-530.
39. Haskell WL, Camargo C Jr, Williams PT, et al. The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. A controlled study. N Engl J Med 1984; 310: 805-810.
40. Krauss RM, Dreon DM,. Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men. Am J Clin Nutr 1995; 62: 478S-487S.